Galicia To Invest €805 Million In Biotechnology, Including Alternative Proteins

Galicia has announced an investment of €805 million in biotechnology over the next five years, with a focus on alternative proteins. The strategic plan, running from 2026 to 2030, aims to boost scientific excellence and competitiveness in the region. The investment includes both public and private capital, with a particular emphasis on four sub-sectors: marine resources, health and pharmaceuticals, bioeconomy and environmental sustainability, and agri-food and foodtech, with a focus on alternative proteins like cultivated meat.

Last year, Galicia saw its first plant-based protein plant established with investments from both public and private entities. The region aims to not only research biotechnology but also create, scale, finance, and internationalize innovations in the field. The plan will also incorporate artificial intelligence and health data to drive advancements in biotechnology, with the potential to transform food design and have applications in various important fields.